PM4Onco: personalized medicine for oncology Effective use of data for molecular tumor boards
Onkologie (Heidelberg, Germany)
2024
30
10
898-904
Prognostic impact of targetable driver alterations in resected early-stage lung cancer.
Transl Lung Cancer Res
2024
13
11
3096-3105
Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma.
Clin Cancer Res
2024
30
9
1859-1877
Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37+ lymphoid malignancies.
Blood
2024
144
11
1153-1167
Recovery of the Intestinal Microbiome in Patients at Day+100 after Allogeneic Stem Cell Transplantation Is Defined By Microbial Metabolite Profiles and Linked to Long-Term Outcomes
Blood
2024
144 Suppl 1
781-781
Gene editing of hematopoietic stem cells restores T-cell response in familial hemophagocytic lymphohistiocytosis.
J Allergy Clin Immunol
2024
153
1
243-255.e14
Loss of Microbiota-Derived Metabolites Is Associated with Mucosal-Barrier-Injury Bloodstream Infection in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Blood
2024
144 Suppl 1
4905-4905
Immunomodulatory Microbial Metabolites Protect Against Graft-Vs-Host Disease and Enhance Anti-Leukemia Responses in Mice and Patients Receiving Stem Cell Transplantation
Blood
2024
144 Suppl 1
264-265
Single-Cell Transcriptomics of Bone Marrow Mesenchymal Stromal Cells Identifies Altered CLCF1 Signaling in DNMT3A-Mutated Clonal Hematopoiesis
Blood
2024
144 Suppl 1
2676-2677
ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease.
Nat Commun
2024
15
1